This corrects the article "The Role of Lovastatin in Curative Chemoradiotherapy for Patients with Head and Neck Cancer: A Randomized Trial" in volume 15, number 2:117-127.

Erratum to “The Role of Lovastatin in Curative Chemoradiotherapy for Patients with Head and Neck Cancer: A Randomized Trial”

Sharifian A, Aghili M. The role of lovastatin in curative chemoradiotherapy for patients with head and neck cancer: a randomized trial. Middle East J Cancer. 2024;15(2):117-27. doi:10.30476/mejc.2023.97387.1911

In the originally published version of the article, authors Ehsan Karbasi, Ali Kazemian, Forouzan Nourbakhsh, and Reza Nazari were erroneously omitted. The authors and their affiliations have now been corrected in the article. Below is the updated list of authors and corresponding affiliations:

Azadeh Sharifian^♦, MD, Ehsan Karbasi, MD, Ali Kazemian, MD, Forouzan Nourbakhsh, MD, Reza Nazari, MD, Mahdi Aghili, MD

Radiation Oncology Research Center, Cancer Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran